C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2011
08/25/2011	WO2011011522A3 Potent small molecule inhibitors of autophagy, and methods of use thereof
08/25/2011	WO2011003528A3 Substituted phenyl(oxy/thio)alkanol derivatives
08/25/2011	US20110207773 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors
08/25/2011	US20110207763 8-carboxamido-2,6-methano-3-benzazocines
08/25/2011	US20110207735 Cyanopyrimidinones
08/25/2011	US20110207729 Bicyclic acylguanidine derivative
08/25/2011	US20110207714 Serotonin receptor modulators
08/25/2011	US20110207157 Labelling of Fusion Proteins With Synthetic Probes
08/25/2011	CA2790692A1 Triazolones as fatty acid synthase inhibitors
08/25/2011	CA2790277A1 Dihydrofuran derivatives as insecticidal compounds
08/24/2011	EP2360155A1 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity
08/24/2011	EP2358705A1 (r) -3- (e) -2- (pyrr0lidin-3-yl) vinyl) -5- (tetrahydr0pyran-4-yl0xy) pyridine, its salts, its synthesis and its use as ligand for nicotinic acetylcholinergic receptors
08/24/2011	EP2358700A1 Pyrrole derivatives for use as plant growth regulators
08/24/2011	EP2358697A1 Isoindoline compounds for use in the treatment of cancer
08/24/2011	EP2358684A1 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
08/24/2011	EP2358682A2 Isoquinolone derivatives as inhibitors of plavivirus replication
08/24/2011	EP2358681A1 Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators
08/24/2011	EP2358678A1 Process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides
08/24/2011	EP2358666A1 A novel process for the preparation of lapatinib and its pharmaceutically acceptable salts
08/24/2011	EP2358200A1 Substituted bicyclic amines for the treatment of diabetes
08/24/2011	EP1485353B1 New inhibitors of histone deacetylase
08/24/2011	CN102164917A Compounds which selectively modulate the CB2 receptor
08/24/2011	CN102164916A Compounds which selectively modulate the CB2 receptor
08/24/2011	CN102164911A 1H-benzimidazole-5-carboxamides as anti-inflammatory agents
08/24/2011	CN102164909A Pyrine or pyrazine derivatives for treating HCV
08/24/2011	CN102161656A Caspase inhibitors and uses thereof
08/24/2011	CN102161655A Apigenin derivatives and preparation method and applications thereof
08/24/2011	CN102161653A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof
08/24/2011	CN101472580B Therapeutic or prophylactic agent for allergic dermatitis
08/24/2011	CN100999519B (-) poly thaazoleazine methylsulfonate, its preparation process and use
08/23/2011	US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/23/2011	US8003799 Picolinic acid derivatives and their use as fungicides
08/23/2011	US8003798 Respiratory system disorders
08/23/2011	US8003693 Modulation of anxiety through blockade of anandamide hydrolysis
08/23/2011	US8003660 Modulators of muscarinic receptors
08/23/2011	CA2656535C Alkyne-substituted pyridone compounds and methods of use
08/23/2011	CA2489452C Phenylaminopyrimidines and their use as rho-kinase inhibitors
08/23/2011	CA2483162C Use of 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino benzo[b]thiophene-2-carboxylic acid derivatives as il-4 inhibitors
08/23/2011	CA2451006C 1,2,4-trioxolane antimalarials
08/18/2011	WO2011099947A1 A new class of highly apoptotic anti-cancer agents
08/18/2011	WO2011099443A1 Β-dihydrofuran deriving compound, method for producing β-dihydrofuran deriving compound or β-tetrahydrofuran deriving compound, β-glycoside compound, method for producing β-glycoside compound, and method for producing 4'-ethynyl d4t and analogue compounds thereof
08/18/2011	WO2011099442A1 Process for preparation of β-glycoside compounds
08/18/2011	WO2011099305A1 5-ht4 receptor agonists for the treatment of dementia
08/18/2011	WO2011098776A1 5-ht receptor modulators
08/18/2011	WO2011080751A3 α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
08/18/2011	US20110201640 Tricyclic compound
08/18/2011	US20110201610 Aryl sulfonamides
08/18/2011	US20110201606 Pyrimidine derivatives
08/18/2011	US20110201602 Protein kinase modulators and method of use
08/18/2011	US20110201589 New bradykinin b1 antagonists
08/18/2011	US20110201583 Guanidine-containing compounds useful as muscarinic receptor antagonists
08/18/2011	CA2789806A1 5-ht receptor modulators
08/18/2011	CA2789663A1 5-ht4 receptor agonists for the treatment of dementia
08/17/2011	EP2357182A1 Inhibitors of tyrosine kinases
08/17/2011	EP2357181A1 2,4-Diaminopyrimidines as inhibitors of cell cycle kinases
08/17/2011	EP2357173A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them
08/17/2011	EP2357169A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
08/17/2011	EP2356107A1 Substituted (pyridyl)-azinylamine derivatives as fungicides
08/17/2011	EP2356106A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
08/17/2011	EP2356103A1 Novel pyrazolone-derivatives and their use as pd4 inhibitors
08/17/2011	EP2356094A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
08/17/2011	EP2355659A1 Fused heterocyclic m1 receptor positive allosteric modulators
08/17/2011	EP2238129B1 A method for the preparation of darifenacin hydrogen bromide
08/17/2011	EP2190836B1 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
08/17/2011	EP2167494B1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
08/17/2011	EP2094656B1 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0}
08/17/2011	EP1896422B1 Tyrosine kinase inhibitors
08/17/2011	EP1812389B1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/17/2011	EP1797069B1 Hiv inhibiting 5-heterocyclyl pyrimidines
08/17/2011	EP1797048B1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
08/17/2011	EP1761505B1 Pyrimidine urea derivatives as kinase inhibitors
08/17/2011	EP1572200B1 Aminoindazole derivatives and use thereof as kinase inhibitors
08/17/2011	EP1485360B1 Sodium channel blockers
08/17/2011	EP1246808B1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
08/17/2011	EP0853618B1 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n- (aminoiminomethyl)phenylalkyl -azaheterocyclylamide compounds
08/17/2011	CN1913886B 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
08/17/2011	CN1894236B Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
08/17/2011	CN1878766B Methods for synthesizing quinolinone compounds
08/17/2011	CN102159562A Chromene modulators of chemokine receptor activity
08/17/2011	CN102159548A Amide compounds useful in therapy
08/17/2011	CN102159545A Small molecule leptin receptor modulators
08/17/2011	CN102159207A Substituted pyrrolidine-2-carboxamides
08/17/2011	CN102153606A Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof
08/17/2011	CN102153544A Preparation method and application of novel tyrosine kinase inhibitors
08/17/2011	CN102153539A 3-aminopyrrolidine derivatives as modulators of chemokine receptors
08/17/2011	CN102153508A 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone and application of the 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone in preparing antitumour drugs
08/17/2011	CN102151273A 2,4,6-triamino-1,3,5-triazine derivative
08/17/2011	CN102151270A Pyrimidine derivatives for the prevention of HIV infection
08/17/2011	CN101331626B Organic electroluminescence element material and organic electroluminescence element using same
08/17/2011	CN101184728B Peptide deformylase (PDF) inhibitors 4
08/17/2011	CN101010296B Piperazine derivatives of alkyhydroxy indole
08/16/2011	US7999109 CCR9 inhibitors and methods of use thereof
08/16/2011	US7998986 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors
08/16/2011	US7998973 Tivozanib and temsirolimus in combination
08/16/2011	US7998963 Arylpiperazine derivatives and uses thereof
08/16/2011	US7998961 For treating conditions associated with UDP-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC)
08/16/2011	CA2482655C Substituted indoles
08/11/2011	WO2011096461A1 Quinoline derivative
08/11/2011	WO2011095625A1 1,2,4-triazine-4-amine derivatives
08/11/2011	WO2011095450A1 Cyclohexyl amide derivatives as crf receptor antagonists

1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 694